US2022274949A1PendingUtilityA1
Compositions and methods comprising substituted 2-aminoimidazoles
Est. expiryMar 31, 2037(~10.7 yrs left)· nominal 20-yr term from priority
C07D 233/88C07D 405/04A61P 35/00C07D 401/04C07D 487/04
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention presents 2-(acylamino)imidazoles with therapeutic activity, including selective activity against cancer cells, and compositions comprising them. Methods of using and preparing the 2-(acylamino)imidazoles are also presented.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of selectively preparing a 2-acylamino 4-substituted imidazole, the method comprising the steps:
monoalkylating an α-amino acid, ester, or amide at the α-amino group; converting the α-alkylamino acid, ester, or amide to an α-alkylamino ketone; cyclizing the α-alkylamino ketone and an acyl cyanamide to form a 2-N-acyl imidazolidin-2-imine product; and converting the 2-N-acyl imidazolidin-2-imine to a 2-acylamino 4-substituted imidazole product; wherein the 2-acylamino product is substantially free from 1-acyl and 3-acyl regioisomers.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.